Predicting the outcomes of targeted temperature management for children with seizures and/or impaired consciousness accompanied by fever without known etiology.

Abstract

BACKGROUND:

Seizures and/or impaired consciousness accompanied by fever without known etiology (SICF) is common in the pediatric emergency setting. No optimal strategy for the management of SICF in childhood currently exists. We previously demonstrated the effectiveness of targeted temperature management (TTM) against SICF with a high risk of morbidity; however, some patients with SICF develop neurological sequelae despite TTM, which necessitate additional neuroprotective treatment. The clinical characteristics of these severe cases have not been studied. Accordingly, the aim of this study was to identify the clinical characteristics of children with SICF who exhibit poor outcomes after TTM.

METHODS:

The medical records of children admitted to Kobe Children's Hospital (Kobe, Japan) between October 2002 and September 2016 were retrospectively reviewed. Patients with SICF treated using TTM were included and divided into the satisfactory and poor outcome groups. Univariate and multivariate logistic regression analyses were used to compare clinical characteristics and laboratory findings between the two groups.

RESULTS:

Of the 73 included children, 10 exhibited poor outcomes. Univariate logistic regression analysis revealed that acute circulatory failure before TTM initiation, the use of four or more types of anticonvulsants, methylprednisolone pulse therapy, and an aspartate aminotransferase (AST) level ≥73 IU/L were associated with poor outcomes. Multivariate logistic regression analysis identified an elevated AST level as a significant independent predictor of a poor outcome.

CONCLUSIONS:

An elevated AST level within 12 h of onset in children with SICF is an independent predictor of a poor outcome after TTM initiated within 24 h of onset.

• Authors: Tsukasa Tanaka, Hiroaki Nagase, Hiroshi Yamaguchi, Yusuke Ishida, Kazumi Tomioka, Masahiro Nishiyama, Daisaku Toyoshima, Azusa Maruyama, Kyoko Fujita, Kandai Nozu, Noriyuki Nishimura, Hiroshi Kurosawa, Ryojiro Tanaka, Kazumoto Iijima
• Journal: Brain & development (Brain Dev) Vol. 41 Issue 7 Pg. 604-613 (Aug 2019) ISSN: 1872-7131 [Electronic] Netherlands
• PMID: 30929765 (Publication Type: Journal Article)
• Copyright: Copyright © 2019 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Chemical References

• Anticonvulsants
• Biomarkers, Pharmacological
• Aspartate Aminotransferases

Topics

• Adolescent
• Anticonvulsants (therapeutic use)
• Aspartate Aminotransferases (analysis, blood)
• Biomarkers, Pharmacological (blood)
• Child
• Child, Preschool
• Consciousness
• Female
• Fever (etiology)
• Fever of Unknown Origin (therapy)
• Humans
• Hypothermia, Induced (adverse effects, methods)
• Infant
• Japan
• Male
• Prognosis
• Retrospective Studies
• Seizures (drug therapy)
• Temperature
• Treatment Outcome